1. Gies A, Cuk K, Schrotz-King P, Brenner H. Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening. Gastroenterology [Internet]. 2018;154(1):93-104. [ DOI:10.1053/j.gastro.2017.09.018] [ PMID] 2. SoffianID SSS, 1, Nazarudin Safian1*, Azmawati Mohammed Nawi1, Shahrul Bariyah Ahmad2‡, Huan-Keat Chan3 MRAH. Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities. PLOS ONE; 2021. p. 11. 3. Ramezani_Doroh V, Delavari A, Yaseri M, Emamgholipour Sefiddashti S, Akbarisari A. Preferences of Iranian average risk population for colorectal cancer screening tests. Int J Health Care Qual Assur [Internet]. 2019 Jan 1;32(4):677-87. [ DOI:10.1108/IJHCQA-08-2017-0151] [ PMID] 4. Alatise OI, Dare AJ, Akinyemi PA, Abdulkareem FB, Olatoke SA, Knapp GC, et al. Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria. Vol. 10, The Lancet Global Health. 2022. p. e1012-22. [ DOI:10.1016/S2214-109X(22)00121-8] [ PMID] 5. Skyrud KD, Myklebust TÅ, Bray F, Eriksen MT, De Lange T, Larsen IK, et al. How many deaths from colorectal cancer can be prevented by 2030? a scenario-based quantification of risk factor modification, screening, and treatment in Norway. Cancer Epidemiol Biomarkers Prev. 2017;26(9):1420-6. [ DOI:10.1158/1055-9965.EPI-17-0265] [ PMID] 6. M. Araghi, M. Arnold, F. Bray IS. Global trends and projections in colorectal cancer mortality. 2018; [ DOI:10.1016/j.respe.2018.05.021] 7. Bnard F, Brkun AN, Martel M, Von Renteln D. Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendations. World J Gastroenterol. 2018;24(1):124-38. [ DOI:10.3748/wjg.v24.i1.124] [ PMID] [ ] 8. Taylor V, Lessler D, Mertens K, Tu SP, Hart A, Chan N, et al. Colorectal cancer screening among African Americans: The importance of physician recommendation. J Natl Med Assoc. 2003;95(9):806-12. 9. Lau J, Lim TZ, Jianlin Wong G, Tan KK. The health belief model and colorectal cancer screening in the general population: A systematic review. Prev Med Reports [Internet]. 2020 Dec 1;20:101223. [ DOI:10.1016/j.pmedr.2020.101223] [ PMID] [ ] 10. Huang J, Wang J, Pang TWY, Chan MKY, Leung S, Chen X, et al. Does theory of planned behaviour play a role in predicting uptake of colorectal cancer screening? A cross-sectional study in Hong Kong. BMJ Open. 2020;10(8):1-9. [ DOI:10.1136/bmjopen-2020-037619] [ PMID] [ ] 11. Taheri-Kharameh Z, Noorizadeh F, Sangy S, Zamanian H, Shouri-Bidgoli AR, Oveisi H. Factors associated with adherence to colorectal cancer screening among moderate risk individuals in Iran. Asian Pacific J Cancer Prev. 2016;16(18):8371-5. [ DOI:10.7314/APJCP.2015.16.18.8371] [ PMID] 12. Abbas Ali Ramazani, Ensiyeh Norozi, Hassan AmirabadiZadeh ARE& HS. Predictors of Colorectal Cancer Screening Participation in Southern Khorasan (Iran). J Gastrointest Cancer. 2020; [ DOI:10.1007/s12029-020-00379-y] [ PMID] 13. LAWSHE CH. a Quantitative Approach To Content Validity. Pers Psychol. 1975;28(4):563-75. [ DOI:10.1111/j.1744-6570.1975.tb01393.x] 14. Almurshed KS. Colorectal cancer: Case-control study of sociodemographic, lifestyle and anthropometric parameters in Riyadh. East Mediterr Heal J. 2009;15(4):817-26. [ DOI:10.26719/2009.15.4.817] 15. Pallesen AVJ, Herrstedt J, Westendorp RGJ, Mortensen LH, Kristiansen M. Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study. Acta Oncol (Madr) [Internet]. 2021;60(3):323-32. [ DOI:10.1080/0284186X.2020.1869829] [ PMID] 16. Zhu X, Weiser E, Jacobson DJ, Griffin JM, Limburg PJ, Finney Rutten LJ. Provider-perceived barriers to patient adherence to colorectal cancer screening. Prev Med Reports [Internet]. 2022;25:101681. [ DOI:10.1016/j.pmedr.2021.101681] [ PMID] [ ] 17. Azeem E, Gillani SW, Poh V, Sulaiman SAS, Baig MR. Barriers to colorectal cancer screening in Asia: A systematic review. Trop J Pharm Res. 2016;15(7):1543-8. [ DOI:10.4314/tjpr.v15i7.26] 18. Hawley ST, McQueen A, Bartholomew LK, Greisinger AJ, Coan SP, Myers R, et al. Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice. Cancer. 2012;118(10):2726-34. [ DOI:10.1002/cncr.26551] [ PMID] [ ] 19. Christian von Wagner, Claudia Semmler, Anna Good JW. Health literacy and self-efficacy for participating in colorectal cancer screening: The role of information processing. Patient Educ Couns. 2009;75(3). [ DOI:10.1016/j.pec.2009.03.015] [ PMID] 20. Sieverding M, Matterne U, Ciccarello L. What role do social norms play in the context of men's cancer screening intention and behavior? Application of an extended theory of planned behavior. Health Psychol. 2010;29(1):72-81. [ DOI:10.1037/a0016941] [ PMID] |
